Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice
Recent reports provide evidence-based guidelines for the withdrawal of inhaled corticosteroids (ICS) in COPD, but data on patients treated with ICS-based triple therapy are sparse and contradictory. We assessed the effect of ICS discontinuation on the incidence of severe exacerbation and pneumonia i...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Taylor & Francis Group
2022-12-01
|
| Seria: | COPD |
| Hasła przedmiotowe: | |
| Dostęp online: | http://dx.doi.org/10.1080/15412555.2022.2045265 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
